The Biotech Triangle

Editor's Note: This is the fourth and final installment this year of a series that focuses on regional hot spots in the United States John Hamer, a tenured professor of microbiology at Purdue University, decided he had reached the top of the academic career ladder three years ago and wanted more involvement in technology development. With the genomics and bioinformatics revolution under way, Hamer had his pick of companies and cities. But rather than relocating to an urban biotech center in Cal

Written byTed Agres
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Bounded by Raleigh, Durham, and Chapel Hill-each with a major university-the Research Triangle represents the nation's fifth-largest biotech location, following Boston, San Francisco, San Diego, and Washington, D.C.3 A biotech bastion in a bucolic setting, the Triangle weds world-class academics and innovation with a gorgeous rural environment. In 2000, Money Magazine rated the region the best place to live in the South and the fourth-best place to live in the entire United States.

Today, Hamer is vice president for research for Paradigm Genetics Inc., a 230-employee functional genomics and bioinformatics company with an agricultural focus. Paradigm is one of more than 140 biotech and high-tech companies in the 7,000-acre Research Triangle Park, the largest such enterprise in the country. Three major research institutions form the vertices of the imaginary triangle that gives the park its name: Duke University at Durham, the University of North Carolina (UNC) at Chapel Hill, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies